Enorama Pharma AB's total assets for Q2 2025 were kr24.99M, a decrease of -29.50% from the previous quarter. SE:ERMA total liabilities were kr16.71M for the fiscal quarter, a -36.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.